Soleno Therapeutics (SLNO) EBT: 2013-2024
Historic EBT for Soleno Therapeutics (SLNO) over the last 9 years, with Dec 2024 value amounting to -$175.8 million.
- Soleno Therapeutics' EBT fell 183.62% to -$5.2 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$12.2 million, marking a year-over-year decrease of 17.41%. This contributed to the annual value of -$175.8 million for FY2024, which is 353.15% down from last year.
- As of FY2024, Soleno Therapeutics' EBT stood at -$175.8 million, which was down 353.15% from -$38.8 million recorded in FY2023.
- In the past 5 years, Soleno Therapeutics' EBT registered a high of -$24.1 million during FY2022, and its lowest value of -$175.8 million during FY2024.
- In the last 3 years, Soleno Therapeutics' EBT had a median value of -$38.8 million in 2023 and averaged -$79.6 million.
- Data for Soleno Therapeutics' EBT shows a maximum YoY tumbled of 353.15% (in 2024) over the last 5 years.
- Over the past 3 years, Soleno Therapeutics' EBT (Yearly) stood at -$24.1 million in 2022, then tumbled by 61.04% to -$38.8 million in 2023, then tumbled by 353.15% to -$175.8 million in 2024.